Feasibility of a Sprint Interval Training Program During Inpatient Spinal Cord Injury Rehabilitation
- Disease/Condition
- Spinal Cord Injuries
- Drug/Device/Intervention
- Sprint Interval Training (SIT)
- Study type
- Interventional
- Intervention type
- behavioral
- Primary sponsor
- University of Washington
- Location
- Seattle, United States of America
- Phase
- N/A
- Start date
- Aug 23, 2023
- End date
- Aug 01, 2025
- Enrollment
- 32 participants
Total physical activity (vector magnitude) per week,Percentage of participants that complete at least six Sprint Interval Training (SIT) sessions,Total number of Ergometer (ERGO) sessions that participants complete between treatment completion and 6 month follow up,Percentage of participants that adhere to Sprint Interval Training sessions and received Motivational Interviewing (MI) sessions
This study will assess the feasibility and efficacy of 3 treatments to increase physical
 activity during and after inpatient rehabilitation (IPR) for new spinal cord injuries:
 
 1. Program of sprint interval training (SIT) on an arm crank ergometer during IPR
 
 2. SIT + Provision of an arm ergometer (ERGO) for home use
 
 3. SIT + ERGO for home use + Motivational interviewing to increase adherence to exercise
 during and after IPR.
 
 The primary outcome is minutes per week of moderate to vigorous physical activity at 6 months
 after IPR discharge. Secondary outcomes include peak power on the 6-Minute Arm Test at IPR
 discharge and self-reported physical activity, depression, fatigue, pain, community
 participation, and quality of life at 6 months after IPR discharge. The investigators will
 obtain data on feasibility, acceptability, and perceived benefits of the treatments from
 stakeholders. The results of this pilot study will inform the design of a larger randomized
 trial.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05989906
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT05989906 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Washington and is currently Enrolling by invitation. The study focuses on Spinal Cord Injuries. Target enrollment is 32 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.